Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients

This study aimed to investigate the pharmacokinetics (PK), safety, and tolerability of a single dose of ceftazidime-avibactam in pediatric patients. A phase I, multicenter, open-label PK study was conducted in pediatric patients hospitalized with an infection and receiving systemic antibiotic therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradley, John S., Armstrong, Jon, Arrieta, Antonio, Bishai, Raafat, Das, Shampa, Delair, Shirley, Edeki, Timi, Holmes, William C., Li, Jianguo, Moffett, Kathryn S., Mukundan, Deepa, Perez, Norma, Romero, José R., Speicher, David, Sullivan, Janice E., Zhou, Diansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2016
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038276/
https://www.ncbi.nlm.nih.gov/pubmed/27503642
http://dx.doi.org/10.1128/AAC.00862-16

Ejemplares similares

Ejemplares similares